Bundle Branch Block and Need for Permanent Pacemaker, a Major Challenge after TAVR

Courtesy of Dr. Carlos Fava.

The development of new valves for TAVR and the increased experienced of operators have significantly decreased paravalvular leak. However, new bundle Branch block (BBB) and the need for permanent pacemaker (PPM) are still relatively high, and their impact and evolution remain controversial.  

Manejo quirúrgico o percutáneo de los leaks mitralesThe study looked at 816 patients, 437 with no conduction disturbances and 247 with BBB, 132 requiring PPM.

 

Mean age was 81, STS was 3.2%, and there were no differences between the groups.

 

At 30 days, there were no differences in mortality.


Read also: TAVR Is Feasible and Offers Good Outcomes in Patients with Cancer.


At 5 years, mortality was higher in the BBB group, followed by the PPM group, compared against patients with no conduction disturbances (48.4% vs. 46.7% vs. 328%, p=0,003). These differences started to show after one year.

 

Rehospitalization for heart failure was higher in patients presenting BBB and PPM, with no differences in hospitalization days between the 3 groups.


Read also: Percutaneous Closure Systems Are Safe in TAVR and Aneurysms.


There was a significant reduction in left ventricular ejection fraction in BBB and PPM patients, compared against patients with no conduction disturbances.

 

Conclusion

The development of BBB and the need for PPM is frequent after TAVR and they are associated to higher mortality risk and higher hospitalization rate due to heart failure.

 

Gentileza del Dr. Carlos Fava.

 

Original title: Mortality and Heart Failure Hospitalization in Patients With Conduction Abnormalities After Transcatheter Aortic Valve Replacement.

Reference: Troels H. Jørgensen, et al. (J Am Coll Cardiol Intv 2019;12:52–61.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...